nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxycycline—MMP7—prostate cancer	0.301	0.542	CbGaD
Doxycycline—MMP13—prostate cancer	0.228	0.411	CbGaD
Doxycycline—SLC22A11—Conjugated Estrogens—prostate cancer	0.0498	0.169	CbGbCtD
Doxycycline—SLC22A11—Estradiol—prostate cancer	0.0437	0.148	CbGbCtD
Doxycycline—SLC22A8—Conjugated Estrogens—prostate cancer	0.0289	0.0983	CbGbCtD
Doxycycline—CYP3A4—prostate cancer	0.0266	0.0479	CbGaD
Doxycycline—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0261	0.0888	CbGbCtD
Doxycycline—SLC22A8—Estradiol—prostate cancer	0.0254	0.0863	CbGbCtD
Doxycycline—SLC22A6—Conjugated Estrogens—prostate cancer	0.0202	0.0685	CbGbCtD
Doxycycline—CYP3A4—Bicalutamide—prostate cancer	0.0137	0.0466	CbGbCtD
Doxycycline—CYP3A4—Estramustine—prostate cancer	0.0128	0.0434	CbGbCtD
Doxycycline—CYP3A4—Flutamide—prostate cancer	0.0114	0.0386	CbGbCtD
Doxycycline—CYP3A4—Abiraterone—prostate cancer	0.0114	0.0386	CbGbCtD
Doxycycline—CYP3A4—Cabazitaxel—prostate cancer	0.00842	0.0286	CbGbCtD
Doxycycline—CYP3A4—Estrone—prostate cancer	0.00823	0.0279	CbGbCtD
Doxycycline—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00733	0.0249	CbGbCtD
Doxycycline—CYP3A4—Conjugated Estrogens—prostate cancer	0.00538	0.0183	CbGbCtD
Doxycycline—CYP3A4—Mitoxantrone—prostate cancer	0.00489	0.0166	CbGbCtD
Doxycycline—CYP3A4—Estradiol—prostate cancer	0.00472	0.016	CbGbCtD
Doxycycline—CYP3A4—Prednisone—prostate cancer	0.00406	0.0138	CbGbCtD
Doxycycline—MMP7—prostate gland—prostate cancer	0.00328	0.112	CbGeAlD
Doxycycline—CYP3A4—Etoposide—prostate cancer	0.00309	0.0105	CbGbCtD
Doxycycline—SLC22A8—urine—prostate cancer	0.00288	0.0988	CbGeAlD
Doxycycline—CYP3A4—Docetaxel—prostate cancer	0.00282	0.00959	CbGbCtD
Doxycycline—MMP7—seminal vesicle—prostate cancer	0.00277	0.095	CbGeAlD
Doxycycline—MMP7—epithelium—prostate cancer	0.00241	0.0825	CbGeAlD
Doxycycline—MMP7—renal system—prostate cancer	0.00224	0.0766	CbGeAlD
Doxycycline—MMP7—urethra—prostate cancer	0.0022	0.0752	CbGeAlD
Doxycycline—MMP1—epithelium—prostate cancer	0.00213	0.0729	CbGeAlD
Doxycycline—CYP3A4—Doxorubicin—prostate cancer	0.0021	0.00715	CbGbCtD
Doxycycline—MMP1—renal system—prostate cancer	0.00197	0.0676	CbGeAlD
Doxycycline—MMP8—bone marrow—prostate cancer	0.00191	0.0655	CbGeAlD
Doxycycline—MMP7—testis—prostate cancer	0.00144	0.0495	CbGeAlD
Doxycycline—CYP3A4—urine—prostate cancer	0.00143	0.049	CbGeAlD
Doxycycline—SLC22A11—renal system—prostate cancer	0.00125	0.0429	CbGeAlD
Doxycycline—MMP8—lymph node—prostate cancer	0.00119	0.0406	CbGeAlD
Doxycycline—Tetracycline—PRNP—prostate cancer	0.0011	0.413	CrCbGaD
Doxycycline—SLC22A8—prostate gland—prostate cancer	0.00104	0.0355	CbGeAlD
Doxycycline—SLC22A8—renal system—prostate cancer	0.000706	0.0242	CbGeAlD
Doxycycline—Minocycline—CASP3—prostate cancer	0.000638	0.239	CrCbGaD
Doxycycline—CYP3A4—renal system—prostate cancer	0.00035	0.012	CbGeAlD
Doxycycline—Minocycline—VEGFA—prostate cancer	0.000296	0.111	CrCbGaD
Doxycycline—Minocycline—MMP9—prostate cancer	0.000286	0.107	CrCbGaD
Doxycycline—Rolitetracycline—CYP3A4—prostate cancer	0.000238	0.0892	CrCbGaD
Doxycycline—Tetracycline—CYP3A4—prostate cancer	0.000109	0.041	CrCbGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—SLC26A4—prostate cancer	2.16e-05	0.000183	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—SLC12A2—prostate cancer	2.16e-05	0.000183	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—prostate cancer	2.14e-05	0.000181	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—GNG5—prostate cancer	2.14e-05	0.000181	CbGpPWpGaD
Doxycycline—CYP3A4—Tryptophan metabolism—CYP1B1—prostate cancer	2.13e-05	0.000181	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—TGFB1—prostate cancer	2.13e-05	0.00018	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—TP53—prostate cancer	2.11e-05	0.000179	CbGpPWpGaD
Doxycycline—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—prostate cancer	2.11e-05	0.000179	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—CASP3—prostate cancer	2.11e-05	0.000179	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—SLC22A3—prostate cancer	2.1e-05	0.000178	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—TGFB1—prostate cancer	2.05e-05	0.000174	CbGpPWpGaD
Doxycycline—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	2.05e-05	0.000174	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—prostate cancer	2.05e-05	0.000174	CbGpPWpGaD
Doxycycline—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—prostate cancer	2.02e-05	0.000171	CbGpPWpGaD
Doxycycline—CYP3A4—Tryptophan metabolism—CYP19A1—prostate cancer	2.01e-05	0.00017	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PLAU—prostate cancer	2e-05	0.000169	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP9—prostate cancer	1.99e-05	0.000169	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—AKT1—prostate cancer	1.99e-05	0.000168	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA2—prostate cancer	1.95e-05	0.000165	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—CAV1—prostate cancer	1.95e-05	0.000165	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—ABCG5—prostate cancer	1.94e-05	0.000164	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—prostate cancer	1.88e-05	0.00016	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—EPHX1—prostate cancer	1.84e-05	0.000156	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—PRKACB—prostate cancer	1.82e-05	0.000154	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—prostate cancer	1.82e-05	0.000154	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—prostate cancer	1.8e-05	0.000152	CbGpPWpGaD
Doxycycline—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—prostate cancer	1.8e-05	0.000152	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—AKT1—prostate cancer	1.78e-05	0.000151	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PIK3CG—prostate cancer	1.78e-05	0.000151	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—EGF—prostate cancer	1.76e-05	0.000149	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—SLC22A3—prostate cancer	1.75e-05	0.000149	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—prostate cancer	1.73e-05	0.000147	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—prostate cancer	1.72e-05	0.000146	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—NCOA2—prostate cancer	1.72e-05	0.000146	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—SLC22A1—prostate cancer	1.71e-05	0.000145	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP7B1—prostate cancer	1.71e-05	0.000145	CbGpPWpGaD
Doxycycline—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—prostate cancer	1.7e-05	0.000144	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP7B1—prostate cancer	1.68e-05	0.000143	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—SULT1E1—prostate cancer	1.66e-05	0.000141	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—prostate cancer	1.66e-05	0.000141	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—CREBBP—prostate cancer	1.65e-05	0.00014	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—prostate cancer	1.64e-05	0.000139	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—TGFB1—prostate cancer	1.64e-05	0.000139	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—SULT1E1—prostate cancer	1.64e-05	0.000139	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.64e-05	0.000139	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—GNG5—prostate cancer	1.63e-05	0.000138	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—IGF1—prostate cancer	1.63e-05	0.000138	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—prostate cancer	1.62e-05	0.000137	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—ABCG5—prostate cancer	1.62e-05	0.000137	CbGpPWpGaD
Doxycycline—CYP3A4—Tryptophan metabolism—CYP1A1—prostate cancer	1.62e-05	0.000137	CbGpPWpGaD
Doxycycline—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—prostate cancer	1.6e-05	0.000136	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—NCOA2—prostate cancer	1.58e-05	0.000134	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—prostate cancer	1.56e-05	0.000133	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PIK3CD—prostate cancer	1.56e-05	0.000132	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—LEP—prostate cancer	1.55e-05	0.000131	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—SERPINE1—prostate cancer	1.55e-05	0.000131	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—NOS3—prostate cancer	1.48e-05	0.000125	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—prostate cancer	1.47e-05	0.000125	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP3A5—prostate cancer	1.46e-05	0.000124	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.45e-05	0.000123	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP3A5—prostate cancer	1.44e-05	0.000122	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—JAK2—prostate cancer	1.43e-05	0.000122	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—SLC22A1—prostate cancer	1.43e-05	0.000121	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GSTA3—prostate cancer	1.41e-05	0.00012	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—prostate cancer	1.4e-05	0.000118	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—GSTA3—prostate cancer	1.39e-05	0.000118	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—PRKACB—prostate cancer	1.39e-05	0.000118	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—RXRA—prostate cancer	1.38e-05	0.000117	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PIK3CB—prostate cancer	1.36e-05	0.000115	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—GNG5—prostate cancer	1.36e-05	0.000115	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	1.33e-05	0.000113	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—INS—prostate cancer	1.32e-05	0.000112	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—prostate cancer	1.31e-05	0.000111	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—NCOA2—prostate cancer	1.31e-05	0.000111	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	1.31e-05	0.000111	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—TBXAS1—prostate cancer	1.29e-05	0.00011	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GSTA4—prostate cancer	1.29e-05	0.00011	CbGpPWpGaD
Doxycycline—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	1.29e-05	0.000109	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—IGF1—prostate cancer	1.28e-05	0.000108	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—GSTA4—prostate cancer	1.28e-05	0.000108	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	1.27e-05	0.000107	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GSTA2—prostate cancer	1.26e-05	0.000107	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—IL2—prostate cancer	1.25e-05	0.000106	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.25e-05	0.000106	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—SULT1A1—prostate cancer	1.24e-05	0.000105	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—MMP2—prostate cancer	1.24e-05	0.000105	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—SULT1A1—prostate cancer	1.23e-05	0.000104	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GSTA1—prostate cancer	1.22e-05	0.000103	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GSTO1—prostate cancer	1.2e-05	0.000102	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—NAT2—prostate cancer	1.2e-05	0.000102	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—NAT2—prostate cancer	1.19e-05	0.0001	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—GSTO1—prostate cancer	1.19e-05	0.0001	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—PRKACB—prostate cancer	1.16e-05	9.83e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP2C18—prostate cancer	1.15e-05	9.77e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP2C18—prostate cancer	1.14e-05	9.63e-05	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—EP300—prostate cancer	1.12e-05	9.51e-05	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.1e-05	9.36e-05	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—NCOA2—prostate cancer	1.09e-05	9.27e-05	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—SRC—prostate cancer	1.09e-05	9.25e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—SULT2A1—prostate cancer	1.07e-05	9.08e-05	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—VEGFA—prostate cancer	1.06e-05	9.01e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	1.06e-05	8.98e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—SULT2A1—prostate cancer	1.06e-05	8.95e-05	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—PPARA—prostate cancer	1.05e-05	8.92e-05	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—RXRA—prostate cancer	1.05e-05	8.9e-05	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.04e-05	8.84e-05	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—CXCL8—prostate cancer	1.03e-05	8.73e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—GPX3—prostate cancer	1.01e-05	8.54e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Tryptophan metabolism—MDM2—prostate cancer	9.97e-06	8.45e-05	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—TGFB1—prostate cancer	9.76e-06	8.27e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—HPGDS—prostate cancer	9.61e-06	8.14e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP2C19—prostate cancer	9.55e-06	8.09e-05	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—CTNNB1—prostate cancer	9.5e-06	8.05e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP2C19—prostate cancer	9.42e-06	7.98e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GSTT1—prostate cancer	9.32e-06	7.9e-05	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—NCOA1—prostate cancer	9.22e-06	7.81e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP2A6—prostate cancer	9.21e-06	7.81e-05	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—KRAS—prostate cancer	9.04e-06	7.66e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—AKR1C3—prostate cancer	8.84e-06	7.49e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP17A1—prostate cancer	8.82e-06	7.48e-05	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—RXRA—prostate cancer	8.77e-06	7.43e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP17A1—prostate cancer	8.7e-06	7.37e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—NCOA2—prostate cancer	8.41e-06	7.12e-05	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—CREBBP—prostate cancer	8.35e-06	7.08e-05	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PIK3CA—prostate cancer	8.3e-06	7.04e-05	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—TP53—prostate cancer	8.03e-06	6.81e-05	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—PPARA—prostate cancer	8.02e-06	6.8e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP2E1—prostate cancer	7.83e-06	6.64e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP2E1—prostate cancer	7.73e-06	6.55e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP1B1—prostate cancer	7.43e-06	6.29e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP1B1—prostate cancer	7.32e-06	6.21e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GGT1—prostate cancer	7.19e-06	6.09e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—NCOA1—prostate cancer	7.08e-06	6e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	6.98e-06	5.92e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	6.89e-06	5.84e-05	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—AKT1—prostate cancer	6.78e-06	5.75e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—RXRA—prostate cancer	6.74e-06	5.71e-05	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—PPARA—prostate cancer	6.7e-06	5.68e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—COMT—prostate cancer	6.49e-06	5.5e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GSTP1—prostate cancer	6.46e-06	5.47e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	6.4e-06	5.42e-05	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.37e-06	5.4e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	6.37e-06	5.4e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GSTM1—prostate cancer	5.94e-06	5.03e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	5.85e-06	4.96e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	5.63e-06	4.77e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—HAO1—prostate cancer	5.55e-06	4.71e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	5.55e-06	4.7e-05	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.32e-06	4.51e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—TST—prostate cancer	4.53e-06	3.84e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GRHL1—prostate cancer	4.53e-06	3.84e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CBR1—prostate cancer	4.53e-06	3.84e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PSAT1—prostate cancer	4.53e-06	3.84e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CSAD—prostate cancer	4.53e-06	3.84e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ADI1—prostate cancer	4.53e-06	3.84e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—UGT2B15—prostate cancer	4.21e-06	3.57e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—UGT2B17—prostate cancer	4.21e-06	3.57e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CKMT2—prostate cancer	4.21e-06	3.57e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GRHPR—prostate cancer	4.21e-06	3.57e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PGAM2—prostate cancer	3.96e-06	3.35e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—MBTPS1—prostate cancer	3.96e-06	3.35e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—AOX1—prostate cancer	3.96e-06	3.35e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NAGLU—prostate cancer	3.96e-06	3.35e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTM3—prostate cancer	3.96e-06	3.35e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—SULT2B1—prostate cancer	3.96e-06	3.35e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—RFK—prostate cancer	3.96e-06	3.35e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP3A43—prostate cancer	3.75e-06	3.18e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—AMACR—prostate cancer	3.75e-06	3.18e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—DEGS1—prostate cancer	3.75e-06	3.18e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—SRD5A2—prostate cancer	3.75e-06	3.18e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NAT1—prostate cancer	3.75e-06	3.18e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—HSD17B1—prostate cancer	3.58e-06	3.03e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—HPGD—prostate cancer	3.19e-06	2.7e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—B4GALT4—prostate cancer	3.19e-06	2.7e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—TNFRSF21—prostate cancer	3e-06	2.54e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP7B1—prostate cancer	2.92e-06	2.47e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—MTAP—prostate cancer	2.92e-06	2.47e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—SULT1E1—prostate cancer	2.84e-06	2.41e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—SRD5A1—prostate cancer	2.84e-06	2.41e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—HSD17B3—prostate cancer	2.71e-06	2.3e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ACSL4—prostate cancer	2.71e-06	2.3e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—UMPS—prostate cancer	2.6e-06	2.2e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PHGDH—prostate cancer	2.6e-06	2.2e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ARG2—prostate cancer	2.6e-06	2.2e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—LDHB—prostate cancer	2.55e-06	2.16e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP3A5—prostate cancer	2.5e-06	2.12e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PDHA1—prostate cancer	2.42e-06	2.05e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—UCP3—prostate cancer	2.42e-06	2.05e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—TCN2—prostate cancer	2.42e-06	2.05e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTA3—prostate cancer	2.42e-06	2.05e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.31e-06	1.95e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.31e-06	1.95e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.21e-06	1.87e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTA4—prostate cancer	2.21e-06	1.87e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTA2—prostate cancer	2.15e-06	1.83e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ABCG5—prostate cancer	2.13e-06	1.8e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.13e-06	1.8e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTA1—prostate cancer	2.08e-06	1.76e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTO1—prostate cancer	2.06e-06	1.74e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.06e-06	1.74e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NAT2—prostate cancer	2.06e-06	1.74e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—LRP2—prostate cancer	1.97e-06	1.67e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.97e-06	1.67e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PLCB2—prostate cancer	1.97e-06	1.67e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—P4HB—prostate cancer	1.93e-06	1.64e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.88e-06	1.59e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.83e-06	1.55e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—MED12—prostate cancer	1.8e-06	1.53e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GNG5—prostate cancer	1.79e-06	1.52e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NCOA3—prostate cancer	1.72e-06	1.46e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—HPGDS—prostate cancer	1.64e-06	1.39e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.63e-06	1.38e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTT1—prostate cancer	1.59e-06	1.35e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ACHE—prostate cancer	1.59e-06	1.35e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.58e-06	1.34e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.53e-06	1.3e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PRKACB—prostate cancer	1.52e-06	1.29e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.51e-06	1.28e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NCOA2—prostate cancer	1.44e-06	1.22e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.37e-06	1.16e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.34e-06	1.14e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NQO1—prostate cancer	1.32e-06	1.12e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—TH—prostate cancer	1.31e-06	1.11e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.27e-06	1.08e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GGT1—prostate cancer	1.23e-06	1.04e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NCOA1—prostate cancer	1.21e-06	1.03e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.19e-06	1.01e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—RXRA—prostate cancer	1.15e-06	9.77e-06	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—COMT—prostate cancer	1.11e-06	9.41e-06	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTP1—prostate cancer	1.1e-06	9.36e-06	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ITPR1—prostate cancer	1.09e-06	9.21e-06	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—TYMS—prostate cancer	1.03e-06	8.7e-06	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTM1—prostate cancer	1.02e-06	8.6e-06	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—LPL—prostate cancer	9.96e-07	8.44e-06	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP1A1—prostate cancer	9.62e-07	8.16e-06	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ERCC2—prostate cancer	9.54e-07	8.09e-06	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—MTHFR—prostate cancer	8.97e-07	7.6e-06	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PPARA—prostate cancer	8.8e-07	7.46e-06	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CAV1—prostate cancer	8.28e-07	7.01e-06	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PIK3CG—prostate cancer	7.54e-07	6.39e-06	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—INS—prostate cancer	7.14e-07	6.05e-06	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CREBBP—prostate cancer	6.99e-07	5.92e-06	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PIK3CD—prostate cancer	6.63e-07	5.62e-06	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NOS3—prostate cancer	6.26e-07	5.3e-06	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PIK3CB—prostate cancer	5.78e-07	4.9e-06	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PTGS2—prostate cancer	5.72e-07	4.85e-06	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PTEN—prostate cancer	4.99e-07	4.23e-06	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—EP300—prostate cancer	4.76e-07	4.03e-06	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.52e-07	2.98e-06	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—AKT1—prostate cancer	2.88e-07	2.44e-06	CbGpPWpGaD
